Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies

Genes and Immunity

Volumn 16, Issue 8, 2015, Pages 541-551

  Maziarz, M ^a   Hagopian, W ^b   Palmer, J P ^a   Sanjeevi, C B ^c   Kockum, I ^c   Breslow, N ^a   Lernmark, A ^d   Graham, Jinko ^e   MacNeney, Brad ^e   Arnqvist, Hans ^f   Landin Olsson, Mona ^d   Nyström, Lennarth ^g   Ohlson, Lars Olof ^h   Östman, Jan ⁱ   Aili, M ^j   Baath, L E ^j   Carlsson, E ^j   Edenwall, H ^j   Forsander, G ^j   Granstrom B W ^k   Gustavsson, I ^j   Hanas, R ^j   Hellenberg, L ^j   Hellgren, H ^j   Holmberg, E ^j   Hornell H ^j   Ivarsson, Sten A ^j   Johansson, C ^j   Jonsell, G ^j   Lindblad, B ^j   Lindh, A ^j   Ludvigsson, J ^j   Myrdal, U ^j   Neiderud, J ^j   Segnestam, K ^j   Skogsberg, L ^j   Stromberg L ^j   Stahle, U ^l   Thalme, B ^j   Tullus, K ^j   Tuvemo, T ^j   Wallensteen, M ^j   Westphal, O ^j   Aman, J ^j   more..

^a UNIVERSITY OF WASHINGTON   (United States)

^b PACIFIC NORTHWEST RESEARCH INSTITUTE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e SIMON FRASER UNIVERSITY   (Canada)

^f LINKÖPING UNIVERSITY   (Sweden)

^g UMEÅ UNIVERSITY   (Sweden)

^h SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j Huddinge University Hospital ^*  (Sweden)

^k Luossavaara Kiirunavara Aktiebolag (LKAB)   (Sweden)

^l Selroos Medical Consulting (Semeco AB)   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 3; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INSULIN AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG; ERBB3 PROTEIN, HUMAN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PTPN22 PROTEIN, HUMAN;

ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADULT; CHILD; GENETICS; IMMUNOLOGY; INFANT; PANCREAS ISLET; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HLA-DQ ANTIGENS; HUMANS; INFANT; ISLETS OF LANGERHANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RECEPTOR, ERBB-3; YOUNG ADULT;

EID: 84949107978     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2015.43     Document Type: Article

References (66)

1. In't Veld P, Marichal M. Microscopic anatomy of the human islet of Langerhans. Adv Exp Med Biol 2010; 654: 1-19.
2. La Torre D, Lernmark A. Immunology of beta-cell destruction. Adv Exp Med Biol 2010; 654: 537-583.
3. Ziegler AG, Nepom GT. Prediction and pathogenesis in type 1 diabetes. Immunity 2010; 32: 468-478.
4. Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 2010; 464: 1293-1300.
5. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004; 89: 3896-3902.
6. Hagopian WA, Erlich H, Lernmark A, Rewers M, Ziegler AG, Simell O et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr Diabetes 2011; 12: 733-743.
7. Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, Simell T et al. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 2002; 87: 4572-4579.
8. Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013; 309: 2473-2479.
9. Andersson C, Vaziri-Sani F, Delli A, Lindblad B, Carlsson A, Forsander G et al. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes. Pediatr Diabetes 2013; 14: 97-105.
10. Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ et al. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies. Diabetes Care 2012; 35: 1213-1218.
11. Krischer JP, Lynch KF, Schatz DA, Ilonen J, Lernmark A, Hagopian WA et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 2015; 58: 980-987.
12. Diabetes Prevention Trial-Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346: 1685-1691.
13. Orban T, Sosenko JM, Cuthbertson D, Krischer JP, Skyler JS, Jackson R et al. Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1. Diabetes Care 2009; 32: 2269-2274.
14. Maziarz M, Janer M, Roach JC, Hagopian W, Palmer JP, Deutsch K et al. The association between the PTPN22 1858C4T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies. Genes Immun 2010; 11: 406-415.
15. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360: 1646-1654.
16. Cooper JD, Howson JM, Smyth D, Walker NM, Stevens H, Yang JH et al. Confirmation of novel type 1 diabetes risk loci in families. Diabetologia 2012; 55: 996-1000.
17. Stene LC, Oikarinen S, Hyoty H, Barriga KJ, Norris JM, Klingensmith G et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010; 59: 3174-3180.
18. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360: 1646-1654.
19. Todd JA. Etiology of type 1 diabetes. Immunity 2010; 32: 457-467.
20. Steck AK, Zhang W, Bugawan TL, Barriga KJ, Blair A, Erlich HA et al. Do non-HLA genes influence development of persistent islet autoimmunity and type 1 diabetes in children with high-risk HLA-DR,DQ genotypes? Diabetes 2009; 58: 1028-1033.
21. Graham J, Hagopian WA, Kockum I, Li LS, Sanjeevi CB, Lowe RM et al. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002; 51: 1346-1355.
22. Afonso G, Scotto M, Renand A, Arvastsson J, Vassilieff D, Cilio CM et al. Critical parameters in blood processing for T-cell assays: validation on ELISpot and tetramer platforms. J Immunol Methods 2010; 359: 28-36.
23. Pipeleers D, Chintinne M, Denys B, Martens G, Keymeulen B, Gorus F. Restoring a functional beta-cell mass in diabetes. Diabetes Obes Metab 2008; 10: 54-62.
24. Sanjeevi CB, Hagopian WA, Landin-Olsson M, Kockum I, Woo W, Palmer JP et al. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8. Tissue Antigens 1998; 51: 281-286.
25. Sanjeevi CB, Lybrand TP, Landin-Olsson M, Kockum I, Dahlquist G, Hagopian WA et al. Analysis of antibody markers, DRB1, DRB5, DQA1 and DQB1 genes and modeling of DR2 molecules in DR2-positive patients with insulin-dependent diabetes mellitus. Tissue Antigens 1994; 44: 110-119.
26. Vandewalle CL, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W et al. Associations of GAD65-and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care 1997; 20: 1547-1552.
27. Williams AJ, Aitken RJ, Chandler MA, Gillespie KM, Lampasona V, Bingley PJ. Autoantibodies to islet antigen-2 are associated with HLA-DRB1 07 and DRB1 09 haplotypes as well as DRB1 04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia 2008; 51: 1444-1448.
28. Delli AJ, Vaziri-Sani F, Lindblad B, Elding-Larsson H, Carlsson A, Forsander G et al. Zinc transporter 8 autoantibodies and their association with SLC30A8 and HLADQ genes differ between immigrant and Swedish patients with newly diagnosed type 1 diabetes in the Better Diabetes Diagnosis study. Diabetes 2012; 61: 2556-2564.
29. Kanatsuna N, Papadopoulos GK, Moustakas AK, Lenmark A. Etiopathogenesis of insulin autoimmunity. Anat Res Int 2012; 2012: 457546.
30. Roep BO, Peakman M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb Perspect Med 2012; 2: a007781.
31. Hermann R, Lipponen K, Kiviniemi M, Kakko T, Veijola R, Simell O et al. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 2006; 49: 1198-1208.
32. Howson JM, Walker NM, Smyth DJ, Todd JA. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun 2009; 10: S74-S84.
33. Lempainen J, Hermann R, Veijola R, Simell O, Knip M, Ilonen J. Effect of the PTPN22 and INS risk genotypes on the progression to clinical type 1 diabetes after the initiation of beta-cell autoimmunity. Diabetes 2012; 61: 963-966.
34. Bottini N, Musumeci L, Alonso A, Rahmouni S, Nika K, Rostamkhani M et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004; 36: 337-338.
35. Rich SS, Concannon P, Erlich H, Julier C, Morahan G, Nerup J et al. The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 2006; 1079: 1-8.
36. Lempainen J, Harkonen T, Laine A, Knip M, Ilonen J. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies. Pediatr Diabetes 2013; 14: 490-496.
37. Butty V, Campbell C, Mathis D, Benoist C. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1). Diabetes 2008; 57: 2348-2359.
38. Gregersen PK. Gaining insight into PTPN22 and autoimmunity. Nat Genet 2005; 37: 1300-1302.
39. Ilonen J, Hammais A, Laine AP, Lempainen J, Vaarala O, Veijola R et al. Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 2013; 62: 3636-3640.
40. Frey MR, Brent Polk D. ErbB receptors and their growth factor ligands in pediatric intestinal inflammation. Pediatr Res 2014; 75: 127-132.
41. Ziegler AG, Bonifacio E. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes. Diabetologia 2012; 55: 1937-1943.
42. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A et al. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 1997; 40: 95-99.
43. Gorus FK, Balti EV, Vermeulen I, Demeester S, Van Dalem A, Costa O et al. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a costeffective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients. Clin Exp immunol 2013; 171: 82-90.
44. Shin JH, Janer M, McNeney B, Blay S, Deutsch K, Sanjeevi CB et al. IA-2 autoantibodies in incident type I diabetes patients are associated with a polyadenylation signal polymorphism in GIMAP5. Genes Immun 2007; 8: 503-512.
45. Roach JC, Deutsch K, Li S, Siegel AF, Bekris LM, Einhaus DC et al. Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden. Am J Hum Genet 2006; 79: 614-627.
46. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark A. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993; 53: 150-167.
47. Graham J, Kockum I, Sanjeevi CB, Landin-Olsson M, Nystrom L, Sundkvist G et al. Negative association between type 1 diabetes and HLA DQB1 0602-DQA1 0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur J Immunogenet 1999; 26: 117-127.
48. Landin-Olsson M, Palmer JP, Lernmark A, Blom L, Sundkvist G, Nystrom L et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulindependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. Diabetologia 1992; 35: 1068-1073.
49. Landin-Olsson M, Karlsson FA, Lernmark A, Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15-to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992; 41: 1022-1027.
50. Larsson HE, Lynch K, Lernmark B, Nilsson A, Hansson G, Almgren P et al. Diabetes-associated HLA genotypes affect birthweight in the general population. Diabetologia 2005; 48: 1484-1491.
51. Nilsson AL, Vaziri-Sani F, Andersson C, Larsson K, Carlsson A, Cedervall E et al. Relationship between Ljungan virus antibodies, HLA-DQ8, and insulin autoantibodies in newly diagnosed type 1 diabetes children. Viral Immunol 2013; 26: 207-215.
52. Graham J, Kockum I, Breslow N, Lernmark A, Holmberg E. A comparison of three statistical models for IDDM associations with HLA. Tissue Antigens 1996; 48: 1-14.
53. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007; 104: 17040-17045.
54. Vaziri-Sani F, Delli AJ, Elding-Larsson H, Lindblad B, Carlsson A, Forsander G et al. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes. J Immunol Methods 2011; 371: 25-37.
55. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-1339.
56. Hagopian WA, Karlsen AE, Gottsater A, Landin-Olsson M, Grubin CE, Sundkvist G et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993; 91: 368-374.
57. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G et al. Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995; 95: 1505-1511.
58. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T et al. Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994; 19: 113-125.
59. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994; 37: 344-350.
60. Mire-Sluis AR, Gaines Das R, Lernmark A. Participants of the study. The World Health Organization International Collaborative Study for Islet Cell Antibodies. Diabetologia 2000; 43: 1282-1292.
61. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994; 13: 505-514.
62. Rabin DU, Pleasic SM, Palmer-Crocker R, Shapiro JA. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992; 41: 183-186.
63. Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes: overlapping specificities to phogrin and ICA512/IA-2. Diabetes 1996; 45: 1344-1349.
64. Olsson ML, Sundkvist G, Lernmark A. Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 327-332.
65. Bonifacio E, Lernmark A, Dawkins RL. Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Methods 1988; 106: 83-88.
66. Agresti A. Categorical Data Analysis 2nd edn (John Wiley & Sons: Hoboken, NJ, USA 2002)